Skip to content

Scinai Immunotherapeutics Ltd.

SCNI· NasdaqCore metricsCIK 1611747

Biological products, except diagnostic substances175 peers

Last sale
Nov 12, 2026 · -9.80%
Market cap
$1.60M
3.47M shares
Filings
499
$1.31M
FY 2025+99.2% FY25 yoy
-$8.31M
FY 2025N/M FY25 yoy
-$7.54M
FY 2025N/M FY25 yoy
-$6.06M
FY 2025derivedN/M FY25 yoy
-$0.00
Q2 2025−60.0% FY23 yoy
$1.66M
FY 2025−15.4% FY25 yoy
$1.60M
—
1.2×
0.2×
-379.45%
—

FY2025 figures · derived

Price

$0.460157.79%$0.6299past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$1.31MFY 2025
$1.31M0FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$1,311,000reported
FY 20242024-12-31$658,000reported

Biological products, except diagnostic substances

Scinai Immunotherapeutics Ltd. is the 77th largest of the 176 covered companies the SEC files under this code, by revenue. SIC 2836

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Scinai Immunotherapeutics Ltd. · CIK 1611747 · Engraved from SEC EDGAR